This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Universitá Degli Studi Di Genova. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Enrico Adriano: Innovator in Medicinal Chemistry
Introduction
Enrico Adriano is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on creatine derivatives. His research focuses on developing therapeutic agents that can aid in cancer treatment.
Latest Patents
Enrico Adriano holds a patent for a creatine derivative known as (Boc)-creatine. This compound is utilized as a medicament, specifically in therapeutic antitumor treatments. His patent represents a significant advancement in the search for effective cancer therapies.
Career Highlights
Enrico Adriano is affiliated with the Università Degli Studi Di Genova, where he conducts his research and development. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to improving patient outcomes through innovative solutions.
Collaborations
Enrico has collaborated with esteemed colleagues such as Patrizia Garbati and Maurizio Balestrino. These partnerships have enriched his research endeavors and contributed to the advancement of medicinal chemistry.
Conclusion
Enrico Adriano's contributions to the field of medicinal chemistry, particularly through his patent on (Boc)-creatine, highlight his role as an innovator in cancer treatment. His work continues to inspire advancements in therapeutic solutions.